BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250114T100000
DTEND;TZID=Europe/London:20250114T120000
DTSTAMP:20260408T152629
CREATED:20241113T200234Z
LAST-MODIFIED:20250116T095307Z
UID:33424-1736848800-1736856000@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: East of England HealthTech Cluster: Connecting People\, Creating Opportunity
DESCRIPTION:              \nThis event\, hosted by Medilink Midlands\, Health Tech Enterprise and SEHTA is the second in a series of growing the East of England MedTech cluster. In this session we will be summarising and feeding back on the gathered opinion of the first event and laying out the next steps for supporting HealthTech in the East of England. \nAttendees will benefit from an expert talk on the deployment of digital health into the primary care sector and we will have a number of SME pitching slots available in which companies can present themselves and highlight any interesting development areas or immediate support needs. \nThere will be ample time given for networking\, to allow delegates to find new connections and share views on the regional needs and focus. \nThis event is also your chance to influence the future of support in the East of England and contribute to shaping the vision of a MedTech Cluster in the region. \nDon’t miss this opportunity to connect\, learn and have your voice heard! \nProgramme:  \n10:00am – Registrations\, Refreshments & Networking  \n10:30am – Strategic Overview & Welcome\, Neil Roberts\, Managing Director\, SEHTA & Dr Anne Blackwood\, CEO\, Health Tech Enterprise \n10:40am – What will be on the GP’s desk in three years time? – A digital health fast forward! Simon Rudland FRCGP\, Chair Suffolk GP Federation\, Visiting Professor of Integrated Digital Health University of Suffolk and Honorary Senior Lecturer Norwich Medical School \n11:00am – Innovator Pitches:  \n\nJohn Cooling\, Director\, Whzan Digital Health\nEashan Saikia\, Co-Founder and CTO\, aseptUVa\nDr James Brown\, Co-Founder & Chief Executive Officer\, Supersense Technologies\nJapeto\nMohammad Najlah\, Interim Director for the Medical Technology Research Centre\, Anglia Ruskin University and Star-Up Founder\nSufiyan Dayam\, Co-Founder\, Medhaya\n\n11:25am – Anglia Ruskin University Support\, Dr Beverley Vaughan\, Arise Innovation Hubs Director\, Anglia Ruskin University \n11:35am – Closing Remarks and Next Steps\, Melanie Davidson\, Chief Executive Officer\, Medilink Midlands \n11:45am – Networking \n12:00pm – Close\n \nTickets: \n£15 plus VAT for members of Medilink. \n£25 plus VAT for non-members. \nNB. Please email events@medilinkmidlands.com for booking codes. \nPlease ensure that you secure your place\, as spaces are limited and available on a first come\, first served basis\, priority will be given to East of England organisations. \n*Please note registration for this event closes at 5pm on Tuesday 7th January. \nSpeaker Profiles:  \n\nMelanie Davidson\, Chief Executive Officer\, Medilink Midlands\nMelanie brings a background of industrial research and business development from West Pharmaceutical Service’s Drug Delivery Division. She also broadens our bioscience reach having studied Animal Science at The University of Nottingham. Before joining Medilink\, Melanie gained valuable experience in economic development and international investment at the East Midlands Development Agency (emda). \n  \n\nDr Anne Blackwood\, CEO\, Health Tech Enterprise\nAnne is Chief Executive of Health Tech Enterprise (HTE)\, a leading NHS innovation and technology consultancy based in Cambridge. Anne has been actively involved in intellectual property management and commercialisation of life science technologies for over 20 years. She is also Chair of the Medtech Accelerator\, a joint venture with public sector partners that awards proof of concept funding to develop medical technologies that meet a clinical need in the NHS. She was formerly Chair and co-founder of Medovate\, a venture backed innovation development company dedicated to the commercialisation of medical technologies created within the NHS. Anne is passionate about improving the quality and efficiency of healthcare services through technology and innovation. \n  \n \nSimon Rudland FRCGP\, Chair Suffolk GP Federation\, Visiting Professor of Integrated Digital Health University of Suffolk and Honorary Senior Lecturer Norwich Medical School\nSimon is an enthusiastic\, innovative\, portfolio GP who has over 30 years of NHS experience. He was a lead GP at Stowhealth working with McLaren Applied Technologies and Proteus as well as other companies. In 2019 he took up a three contract as a visiting GP on the remote island of Hoy in Orkney. He supports general practice at scale and undergraduate education recognising how important digital health is to community care. Through his work as a Clinical Advisor with Health Innovation East he has been privileged to work with some game changing technologies. \n  \n\nDr Beverley Vaughan\, Arise Innovation Hubs Director\, Anglia Ruskin University\nBeverley joined the Arise Innovation Hubs as Director in June 2021\, with over 20 years’ experience in the healthcare and life sciences sector. Beverley trained as a clinical scientist in Haematology and working at Cambridge and London University Hospitals.  Working in the innovation sector for the last 10 years with roles in Stevenage Bioscience Catalyst (SBC)\, Cell and Gene Therapy Catapult (CGT) and the University of Oxford.  Whilst at SBC Beverley supported the development of translational research facilities and raised funding from multiple pharma and biotech companies for the Open Innovation Challenge in Neurodegeneration. At CGT Beverley managed a wide portfolio of project from novel drug discovery spin outs to NHS led delivery of cell therapy products. Most recently she was responsible for the delivery of a drug discovery consortium-UKSPINE- pivoting traditional pathways to meet the demands of healthy aging with partners\, Universities of Oxford\, Dundee and Birmingham\, Medicines Discovery Catapult\, The Francis Crick Institute and Sanger Centre Cambridge.  Since joining Arise as Director Beverley has been working on building the life science strategy for their newest hub located on the Harlow Innovation Park\, leading on strategy\, fund raising and partnering activities to build a cluster of expertise within this synapse of the London-Cambridge corridor. She is also a member of the NC3Rs CRACKIT advisory panel. \n  \n \nNeil Roberts\, Managing Director\, SEHTA \nNeil has been the Managing Director since April 2021\, having previously been COO since July 2018. In July 2022\, Neil was appointed non-executive Chairman to the Board of Exhalation Technology Ltd\, which has attracted more than £11m in investor funding. In addition he is a business Mentor at Imperial College\, London\, as part of the Imperial Venture Mentoring Service.\nBased on more than 30 years as a Senior Executive in the medical technology market\, he has a track record of success in driving business development and growth\, via sales and marketing\, domestic and international distributor management\, market access\, major accounts\, new business integration\, and change management. This has been gained in the UK and in export both within an SME and market leading corporate environment.  His approach is based on pragmatism\, enabled by detailed market understanding\, with the highest importance placed on the execution of consequent action plans as the key to success.  He has managed product though NICE Technology Appraisal (TA)\, and other market access processes.  Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK\, and as Chair of the Ophthalmic Special Interest Group at the ABHI.  A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership studies at Harvard. \n  \n\nJohn Cooling\, Director\, Whzan Digital Health\nJohn joined Whzan in December 2014 having established Haverstock Healthcare in 2008\, a GP federation of 29 Practices delivering primary and some secondary care services to approximately 500\,000 NHS patients in North London. Since joining Whzan John has helped the Company to expand its healthcare services across the NHS and developed social care technology to support vulnerable people accessing social care. Previously\, John served as a Director and Chairman of Microlease PLC from 1991 until 2006. Microlease is now part of Electrorent\, the largest global provider of test and measurement applications. John also served as Chief Executive of Goodhead Group PLC from 1993 until May 2006.  John is also a partner with LGF Partners\, a London based debt advisory boutique for early stage and fast growth companies. \n  \n \nEashan Saikia\, Co-founder & Chief Technology Officer (CTO)\, aseptUVa\nEashan is the co-founder and CTO of Aseptuva – a MedTech startup based in Cambridge\, UK\, developing an automated disinfection system based on guided Far-UVC light to prevent microbial contamination of catheter-entry sites in patients and prevent hospital acquired infections that affect nearly 800\,000 patients annually in the UK. Their solution will not only prevent patient deaths but can save the NHS billions of pounds in additional costs\, alleviate burden on health workers\, reduce patient discomfort\, and stimulate a shift away from traditional antibiotics.\nEashan has a PhD in Biomechanics from ETH Zurich in Switzerland and is currently leading multiple projects funded by UK Innovate EDGE\, Horizon Europe\, and NIHR\, to bring their innovation into different NHS Trust hospitals. \n  \n\nDr James Brown\, Co-Founder and Chief Executive\, Supersense Technologies\nDr James Brown is the Co-Founder and CEO of Supersense Technologies\, a Cambridge-based technology startup revolutionising dementia care with a privacy-preserving monitoring service that empowers people to stay independent and makes caring easier for families. James is an electronic engineer\, entrepreneur\, and veteran with over a decade of R&D experience in the Ministry of Defence and industry. He leads Supersense Technologies in its mission to empower people to live independently for longer. \n  \nSufiyan Dayam\, Co-Founder\, Medhaya \nMedhaya is an AI-powered healthcare innovation transforming patient care and practitioner efficiency through intelligent triaging and consultation co-pilot tools. Our mission is to streamline healthcare delivery\, making it accessible\, personalised\, and efficient for everyone. \n  \n  \nIngrid Folland\, CEO\, Japeto \nIngrid is a dedicated advocate for tech for good\, committed to local impact. Starting in R&D\, she transitioned into the dynamic world of technology\, taking on various roles including product design\, development\, and project management. Ingrid is now the CEO of Japeto\, a company focused on creating safe AI solutions for charities\, healthcare\, education\, and more.
URL:https://staging.medilinkmidlands.com/event/in-person-event-east-of-england-healthtech-cluster-connecting-people-creating-opportunity/
LOCATION:Arise Innovation Hub\, Harlow Innovation Park\, Maypole Boulevard\, Harlow\, Essex\, CM17 9TX\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250116T103000
DTEND;TZID=Europe/London:20250116T113000
DTSTAMP:20260408T152629
CREATED:20241107T151609Z
LAST-MODIFIED:20250117T083222Z
UID:33323-1737023400-1737027000@staging.medilinkmidlands.com
SUMMARY:ONLINE Event: Tackling Mental Health - A Deep Dive into Tech Driven Solution
DESCRIPTION:As the global demand for mental health support continues to rise\, we explore the pivotal role of technology and innovation in revolutionising treatment.\nThis webinar will delve into the region’s commitment to mental health\, examining how cutting-edge solutions are being developed to address this growing challenge.\nDuring the webinar we will discuss:\n• Regulatory Landscape: Understanding the regulatory framework for med tech in mental health.\n• Innovative Solutions: Exploring the latest advancements from local companies.\n• The Future of Mental Healthcare: Visioning a future where technology empowers mental well-being. \nDon’t miss this opportunity to connect with industry leaders and gain insights into the future of mental health.\n\nSpeaker Information\nPaul Moran – FrameWork Genie \n‘Turning Compliance into Competitive Advantage: A Regulatory Overview’ \nPaul has helped startups and corporations navigate complex change. Working with healthtech startups highlighted the significant challenges they face in securing compliance within a constantly evolving regulatory landscape. Recognising this gap\, he co-founded Framework Genie with Joey to simplify the compliance journey for businesses and accelerate their growth. \n  \n  \n  \n Joey Islam – FrameWork Genie \n‘Turning Compliance into Competitive Advantage: A Regulatory Overview’ \nWe turn compliance into competitive advantage\, and hence drive sales into growth. Whether your business is a startup or SME\, we have the deep knowledge and experience to understand your business quickly\, and we speak the language of regulations so you don’t have to. \n  \n  \n  \n Dr Vicky Queralt – Little Journey \nDr Vicky Queralt is a Clinical Psychologist with extensive experience supporting children\, young people\, and their families in the NHS\, specialist schools\, and independent practice. As part of the team at Little Journey she contributes to the development of digital and downloadable content that supports children and families to navigate healthcare experiences in a supportive\, anxiety-reducing way. She also co-hosts the podcast series Spotlight Session\, which delves into the challenges parents face in accessing healthcare for their children. Vicky creatively uses her professional experience and personal insights as a mum of three to create accessible tools that enhance patient experiences. \n  \n  \n \n  Thomas Rush – Little Journey \nThomas Rush worked as a primary school teacher\, with a focus on early years\, for six years before joining Little Journey in 2022 as a user researcher. A passionate advocate for the ensuring the voice of the child is heard\, Thomas used his connections to form a network of schools where co-creation sessions were hosted as part of a project with the LEGO Foundation\, to guide the development of the Little Journey app. More recently\, Thomas moved into product management at the company. In this role he is guiding the creation of multiple pathways\, in both the UK and US\, to ensure they tackle the greatest pain points for children and their families. His recent focus has been on improving the accessibility and inclusivity of the app for all users\, particularly neurodivergent children\, with the new version of the app launching in November of this year. \n  \n  \nTo read more about Medilink Midlands’ role within the WMHTIA project\, click here. \nFor more information on the wider project\, click here to visit the WMHTIA website. \nThis event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA\, a project funded by the Department for Science\, Innovation and Technology\, Innovate UK and West Midlands Combined Authority (part of City Regions).
URL:https://staging.medilinkmidlands.com/event/tackling-mental-health-a-deep-dive-into-tech-driven-solution/
LOCATION:Online via GoToWebinar
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250130T100000
DTEND;TZID=Europe/London:20250130T113000
DTSTAMP:20260408T152629
CREATED:20241204T123519Z
LAST-MODIFIED:20250130T125052Z
UID:33809-1738231200-1738236600@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medilink Midlands Innovation Builder - calling all applicants
DESCRIPTION:Following our recent announcement of the new innovation support programme\, the Medilink Midlands Innovation Builder\, we are pleased to offer a discovery session to understand how the pilot phase of the programme will be delivered\, and how it plans to help innovators: \n\nDiscover a scalable business model\nBuild a commercial proposition\nGet ready for investment\n\nConveniently presented online\, attendees will hear from Medilink Midlands Entrepreneur in Residence and lead facilitator of the Innovation Builder programme – Christian Kumar. \nChristian will explain the purpose behind the three specific cohort groups\, designed to best serve the exact needs of innovators from across academia and industry. \nWith limited places on each cohort group\, we encourage anyone interested in becoming a cohort member of the programme to attend this discovery session\, as Christian will also cover the guidelines and tips to a successful application*. \nThe three cohort groups\, are: \n\nAlpha Group – dedicated to researchers and academics that have a concept worthy of discussion to formulate the concept into a commercial pathway.   Module “research to revenue” will be delivered through the Medilink Midlands Entrepreneur in Residence program\, mainly online. Initial cohort intake max 40 companies.\nBeta Group – looking for companies that are post concept and pre revenue.  Applicants may have a company or received funding [either private or public].  These applicants will have a formed business and are looking for a corporate strategy to marry their clinical development plan.  Initial cohort intake 20 companies.\nSigma Group – trading companies at any stage looking to scale internationally by funding or strategy.  We will sit alongside the board guiding the growth of the underlying business.   If these companies are not revenue generating\, they will be seeking a series A £5m plus funding round. Initial cohort intake 10 companies.\n\nWith limited places available\, we encourage anyone interested in joining the programme to attend this discovery session\, to find out the application guidelines and tips to a successful application*.  The webinar will allow for delegates to ask questions to both Melanie Davidson\, Chief Executive Officer and Christian Kumar\, Entrepreneur in Residence\, Medilink Midlands. \nWho should attend? \nThis webinar is targeted towards innovators looking to find out more on how the Innovation Builder can support their innovation and pathway to commercialisation and investment readiness. \nThis is not aimed towards service providers\, or those who have registered to be a delivery partner within the programme. \n*applications will go live following the webinar session\, and all information will be found here. \n  \n  \nSpeaker Profiles:  \n \nChaired by: Melanie Davidson\, Chief Executive Officer\, Medilink Midlands\nMelanie brings a background of industrial research and business development from West Pharmaceutical Service’s Drug Delivery Division. She also broadens our bioscience reach having studied Animal Science at The University of Nottingham. Before joining Medilink\, Melanie gained valuable experience in economic development and international investment at the East Midlands Development Agency (emda). \n \n  \n  \nChristian Kumar\, Entrepreneur in Residence\, Medilink Midlands and lead facilitator for Medilink Midlands Innovation Builder\nChristian brings his extensive experience in corporate finance\, investment banking and wealth management. This has been gained over three decades of dedicated involvement in driving strategic growth for various enterprises to help support the ambitions of Medilink Midlands members as they strive to commercialise their own innovations.  Throughout his career\, Christian has honed a profound understanding of strategic growth across diverse sectors\, and is proud to have played a pioneering role in developing “demand-based” business modelling.
URL:https://staging.medilinkmidlands.com/event/webinar-medilink-midlands-innovation-builder-calling-all-applicants/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR